FDA Drug Application (203217) for RISEDRONATE SODIUM by TEVA PHARMS USA

Back to FDA Applications sponsored by TEVA PHARMS USA

Application Number203217
Product Number001
FormTABLET, DELAYED RELEASE;ORAL
Dosage35MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameRISEDRONATE SODIUM
Active IngredientRISEDRONATE SODIUM

Active IngredientCount
List of drugs with Active Ingredient RISEDRONATE SODIUM4


Back to FDA Applications sponsored by TEVA PHARMS USA